Species differences between rats and primates (humans and monkeys) in complex cleavage pathways of DS-8500a characterized by 14C-ADME studies in humans and monkeys after administration of two radiolabeled compounds and in vitro studies
- 19 March 2022
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 45, 100459
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Metabolism of a G Protein-Coupled Receptor Modulator, Including Two Major 1,2,4-Oxadiazole Ring-Opened Metabolites and a Rearranged Cysteine-Piperazine AdductDrug Metabolism and Disposition, 2012
- Metabolism of [14C]GSK977779 in Rats and Its Implication with the Observed Covalent BindingDrug Metabolism and Disposition, 2011
- Reductive Isoxazole Ring Opening of the Anticoagulant Razaxaban Is the Major Metabolic Clearance Pathway in Rats and DogsDrug Metabolism and Disposition, 2008
- Interspecies in vitro metabolism of the phosphodiesterase‐4 (PDE4) inhibitor L‐454,560Journal of Mass Spectrometry, 2006
- Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)CNS Drug Reviews, 2006
- The Role of Mammalian Intestinal Bacteria in the Reductive Metabolism of ZonisamideJournal of Pharmacy and Pharmacology, 1997
- Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amidesNature, 1996
- The use of liquid chromatography/thermospray mass spectrometry with on-line ultraviolet diode array and radiochemical detection: Characterization of the putative metabolites of U-78875 in female rat faecesJournal of Mass Spectrometry, 1994
- Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivativeXenobiotica, 1992
- Metabolic Studies withTrans-5-Amino-3-[2-(5-Nitro-2-Furyl)Vinyl]-1,2,4-[5-14C]Oxadiazole (SQ 18,506): 1. Reductive Cleavage of the 1, 2, 4-oxadiazole ringXenobiotica, 1973